HIV Articles
Back
	HIV/Aging & Antiaging Therapy       Antiaging Therapy with TAT2: Telomerase-Based Pharmacologic ... "We evaluated the effect of short-term exposure to < em style="font-weight: bold; font-style: normal; ">TAT2 on PHA-activated PBMC from 21 individual adult donors, including healthy persons and HIV-infected ... www.natap.org/2009/HIV/060209_01.htm   Early Immune Senescence in HIV Disease Most intriguing are results with a small molecule telomerase activator (TAT2) that modestly retards telomere shortening, increases proliferative potential, ... www.natap.org/2010/HIV/021510_01.htm   Mechanisms and Possible Solutions Similar effects are seen following exposure to a small-molecule telomerase activator, TAT2, which leads to significant increases in proliferation, ... www.natap.org/2009/HIV/052109_02.htm   HIV and aging Selected Articles (06/08/09); Antiaging Therapy with TAT2: Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes - (06/02/09) ... www.natap.org/age.htm   Immunosupportive therapies in aging - pdf attached HAART Does Not Reverse Premature T-Cell Aging Caused by HIV - (02/27/09) ... a change in peripheral T cell subpopulations is found in aging (Effros ... www.natap.org/2010/HIV/020510_02.htm   HAART Does Not Reverse Premature T-Cell Aging Caused b y HIV - (02/27/09) Expression of CD28, CTLA-4 and perforin by CD4 lymphocytes remain dysregulated in HIV-infected patients with previous severe immunodeficiency, despite increased CD4 T-cell counts and control of HIV viraemia by HAART...             view older Articles   Back to Top   www.natap.org